The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.
Influenza A — a nasty flu strain that fueled the 2009 flu epidemic — has been landing Ohioans in the hospital since the ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The California Department of Public Health told SFGATE “elevated rates” of flu hospitalizations also have been reported ...
Flu cases are surging this winter—this season is no joke. New data from the Centers for Disease Control and Prevention ...
More than one million people in England have been urged to get vaccines for respiratory syncytial virus (RSV), with health ...
AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
While RSV infections are common and not usually serious, adults over the age of 75, babies under six months and people with a weakened immune system can become severely ill. The virus can lead to ...
Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results